Original Research
Accepted on 04 Apr 2025
Resolution of Anti-GAD-Associated Autoimmune Encephalitis in Patients Treated with Efgartigimod
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1550023
Type at least 3 characters
1,111 articles
Editorial
Published on 03 Apr 2025
Editorial: Spatial transcriptome and single-cell sequencing for exploring molecular mechanisms of neuroimmunity and discovering novel markers of neurological diseases
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1582019
- 326 views
Original Research
Accepted on 02 Apr 2025
Immunotherapy for Neuromyelitis Optica Spectrum Disorder: A Comparative Analysis of Efficacy and Safety of Azathioprine, Mycophenolate Mofetil, Tacrolimus, and Rituximab
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1559118
Original Research
Published on 02 Apr 2025
Isolated cranial nerve disorder as presenting sign in multiple sclerosis: optic nerve versus “the others”
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1557326
- 237 views
Original Research
Accepted on 31 Mar 2025
Disparities in Patient Share and Characteristics Between Disease-Modifying Therapy-Treated and -Untreated People with Multiple Sclerosis in Germany: A Claims Data Analysis from 2017 to 2022
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1561810
Perspective
Published on 28 Mar 2025
Steps toward the implementation of neurofilaments in multiple sclerosis: patient profiles to be prioritized in clinical practice
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1571605
- 266 views
Original Research
Accepted on 26 Mar 2025
Raman Liquid Biopsy: A New Approach To The Multiple Sclerosis Diagnostics
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1516712
Original Research
Published on 26 Mar 2025
Electroencephalographic biomarkers of antibody-mediated autoimmune encephalitis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1510722
- 440 views
Original Research
Published on 25 Mar 2025
Rituximab treatment in Chinese patients with primary angiitis of the central nervous system
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1554989
- 244 views
Original Research
Published on 17 Mar 2025
Cognitive-motor interference in multiple sclerosis revisited: a dual-task paradigm using wearable inertial sensors and the Paced Auditory Serial Addition Test
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1546183
- 474 views
Original Research
Published on 12 Mar 2025
Efficacy of dexamethasone combined with intravenous immunoglobulin for the treatment of pediatric autoimmune encephalitis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1512908
- 498 views
Original Research
Published on 28 Feb 2025
The clinical value of the neutrophil-to-lymphocyte ratio, systemic immune-inflammation index, monocyte-to-lymphocyte ratio and platelet-to-lymphocyte ratio for predicting the severity of patients with autoimmune encephalitis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1498007
- 484 views
Case Report
Accepted on 24 Feb 2025
Very-Late-Onset Neuromyelitis Optica Spectrum Disorder: A Case Report and Review
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1559872
- 129 views
Review
Published on 18 Feb 2025
Leber’s hereditary optic neuropathy and multiple sclerosis: overlap between mitochondrial disease and neuroinflammation
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1538358
- 1,006 views
Original Research
Published on 17 Feb 2025
Alterations in neutrophil mRNA profiles in multiple sclerosis and identification of candidate genes for further investigation
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1548196
- 871 views
Original Research
Published on 14 Feb 2025
Commercial immunoassays in paraneoplastic neurological syndromes: an Australian laboratory perspective
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2025.1515069
- 536 views